Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Gains 2%; BSE HEALTHCARE Index Up 0.3%
Thu, 27 Jun 11:13

Dr. Reddys Gains 2%; BSE HEALTHCARE Index Up 0.3%Image source: hudiemm/www.istockphoto.com

Dr. Reddys share price has zoomed 2% and is presently trading at Rs 6,201.8.

Meanwhile, the BSE HEALTHCARE index is at 36,809.0 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 6.2%) and MAX HEALTHCARE INSTITUTE (up 5.1%).

KIMS (down 1.9%) and POLY MEDICURE (down 1.5%) are among the top losers today.

Over the last one year, Dr. Reddys has moved up from Rs 5,042.3 to Rs 6,201.8, registering a gain of Rs 1,159.5 (up 23.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,809.0, registering a gain of 45.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 90.1%), Glenmark Pharma (up 89.8%) and GSK Pharma (up 83.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,761.3 (up 0.1%).

The top gainers among the BSE Sensex today are Ultratech Cement (up 3.2%) and JSW Steel (up 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and M&M.

In the meantime, NSE Nifty is at 23,889.5 (up 0.1%). Ultratech Cement and Grasim Industries are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,761.3, registering a gain of 15,791.3 points (up 25.1%).

Dr. Reddys Financial Update...

Dr. Reddys net profit grew 37.1% YoY to Rs 13,063 million for the quarter ended March 2024, compared to a profit of Rs 9,525 million a year ago. Net sales rose 12.6% to Rs 71,138 million during the period as against Rs 63,152 million in January-March 2023.

For the year ended March 2023, Dr. Reddys reported 106.5% increase in net profit to Rs 45,073 million compared to net profit of Rs 21,825 million during FY22. Revenue of the company grew 14.5% to Rs 246,697 million during FY23.

The current Price to earnings ratio of Dr. Reddys, based on rolling 12 month earnings, stands at 18.6.


Equitymaster requests your view! Post a comment on "Dr. Reddys Gains 2%; BSE HEALTHCARE Index Up 0.3%". Click here!